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Abstract
Background: Only a few reports have analyzed low-risk patient outcomes and in every case, the 
risk was based on a logistic EuroSCORE ≤ 2. Since this original EuroSCORE overestimates 
surgical risk, we developed this study to prospectively evaluate the immediate results of cardiac 
surgery in patients with an expected mortality risk ≤ 2% according to the EuroSCORE II  
as a new gold standard. We also examined the cause of death and whether it could be considered 
preventable.
Methods: A prospective risk stratification of all cardiac surgical patients treated at the Bue-
nos Aires University Hospital of Argentina was performed between 2012 and 2014 using the 
EuroSCORE II. Causes of death were classified as preventable or not preventable.
Results: From a total of 990 patients, 63.2% had EuroSCORE II ≤ 2 (low-risk group) and 
32.5% EuroSCORE II < 1 (very low-risk group). In the low-risk group, in-hospital mortal-
ity was 1.8%, whereas predicted mortality was 1.04% (AUC 0.765). The observed/expected 
ratio was 1.73 (95% CI 0.68–4.43) and the observed-expected difference was 0.76 (95% CI 
–0.68–2.10). Fifty-four percent of deaths were considered preventable.
Conclusions: We propose to use and further validate the EuroSCORE II as a new standard 
for assessing low-risk patients. This model proved to be useful in evaluating the quality stand-
ards of local cardiac surgery. The review of cause of death in low-risk patients provided valu-
able information, which revealed potentially correctable issues. Adoption of a more demanding 
standard, as the EuroSCORE II to identify low-risk patients, avoids the sense of safety offered 
by previous versions of the score. (Cardiol J 2015; 22, 5: 495–500)




Developed countries continue to improve qual-
ity standards in cardiac surgery. Today, advances in 
technology, professional competitiveness and popu-
lation expectations demand better and increasingly 
predictable surgical results. The risk stratification 
models used to assess perioperative mortality, such 
as the Society of Thoracic Surgeons mortality risk 
score (STS) [1] and the European System for Cardiac 
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propose rigorous quality standards with commonly 
expected operative risks < 1%.
Behind this process, cardiac surgeons in de-
veloping countries try to reproduce these results. 
However, it is clear that these countries have at 
least a technological limitation that prevents them 
from matching their results with international 
measures. In this sense, technological backward-
ness and infrastructure constraints are valid argu-
ments to justify not attaining the highest quality 
standards. These reasons, however, would only be 
well-founded for patients with severe comorbidi-
ties and high expected risk, where perioperative 
technological support is crucial to make a differ-
ence in the results. Instead, it is in very low-risk 
patients, with an expected lower demand for addi-
tional instrumental support, in whom local cardiac 
surgery should achieve the best quality standards. 
In this situation, there would be a strong and direct 
relationship between outcomes and the individual 
performance of the surgical team during surgery.
To date, only a few reports have analyzed the 
outcomes in low-risk patients, and in every case 
risk has been calculated based on a logistic Euro-
SCORE ≤ 2 [3–7]. Since this original EuroSCORE 
overestimates operative risk [8], we developed 
this study to prospectively evaluate the immedi-
ate results of cardiac surgery in patients with an 
expected mortality risk ≤ 2% according to the 
EuroSCORE II as a new gold-standard. We also 
examined the cause of death and whether it could 
be considered preventable.
Methods
A prospective risk stratification of all cardiac 
surgical patients treated at the Buenos Aires Uni-
versity Hospital of Argentina, Hospital de Clínicas 
“José de San Martín” and its associated Clinics, 
was performed between 2012 and 2014 using the 
EuroSCORE II. Definitions proposed by the Euro-
SCORE II were fully adopted and the risk score was 
determined with an online interactive calculator 
(http://www.euroscore.org/calc.html). Creatinine 
clearance was calculated with the Cockroft-Gault 
formula [9]. All types of surgery were included, 
except acute aortic dissection, transplant and 
transcatheter aortic valve implantation. Patient 
characteristics, surgical details and postopera-
tive outcomes were simultaneously recorded in 
a computer database. Individuals with a score 
≤ 2 were identified from the database and included 
in the study. According to our definition, they 
were categorized as the low-risk group. An extra 
category was defined when the expected risk of 
operative mortality was < 1, and these patients 
were included in the very low-risk group. Only 
patients with EuroSCORE II > 2 were excluded. 
Primary endpoints were in-hospital and 30-day 
all cause-mortality. Major complications, overall 
mortality, cause of death, observed-to-expected 
operative mortality ratio and observed-expected 
difference were calculated. Causes of death were 
classified by 2 senior surgeons and 2 cardiologists 
into 3 categories: not preventable, preventable 
(technical error), or preventable (system error). 
We defined non-preventable death when the cause 
was an unavoidable and unpredictable event such 
as pulmonary embolism, stroke, mediastinitis, sep-
ticemia or sudden death after discharge. Definitions 
of technical and system errors were adopted from 
previous FIASCO studies [3, 4].
Preoperative baseline demographic and clini-
cal comorbid risk variables and operative proce-
dural variables were recorded and analyzed with 
the approval of the institutional review board.
Statistical analysis
Observed mortality was calculated according 
to the number of events reported in each group. 
Observed/expected (O/E) mortality ratio and 
observed-expected (O-E) mortality difference with 
their corresponding 95% confidence intervals (95% 
CI) were calculated for each group. An O/E ratio > 1 
indicated that mortality was higher than predicted 
with the EuroSCORE II, or that the model underes-
timated the relative mortality, whereas a ratio < 1 
showed that mortality was lower than expected, 
or that the model overestimated mortality. If the 
95% CI for the O/E ratio excluded the value 1, this 
was considered statistically significant. Similarly, 
a value of O-E > 0 meant that mortality was higher 
than that predicted with the EuroSCORE II, or 
that the model underestimated absolute mortality, 
whereas a value < 0 indicated that mortality was 
lower, or that the model overestimated mortality. 
If the 95% CI for the O-E difference excluded the 
value 0, this was considered statistically significant. 
For the statistical analysis, continuous variables 
were expressed as mean ± standard deviation 
(SD). The Kolmogorov–Smirnov goodness-of-fit 
test was used to analyze normal distributions, and 
comparison between continuous variables was 
done with Student’s t-test. Univariate comparison 
of dichotomous variables was performed using 
the c² test. Yates’ corrected c² was used when 
cell expected values were between 3 and 5, while 
2-tailed Fisher´s exact test was used when values 
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were below 3. Finally, the area under the receiver 
operating characteristic (ROC) curve (AUC) was 
determined to assess EuroSCORE II performance. 
Data analysis was performed with SPSS Statistics 
for Windows, Version 17.0 (Chicago: SPSS Inc.) 
and Epi InfoTM 7.1.3.0, and a p value ≤ 0.05 was 
considered statistically significant.
Results
Between 2012 and 2014, 990 adult patients 
underwent cardiac surgery at our institution, 626 
(63.2%) of whom were identified as having Euro-
SCORE II ≤ 2 (low-risk group) and 322 (32.5%) 
EuroSCORE II < 1 (very low-risk group). Popula-
tion characteristics and the immediate postoperative 
adverse events in both groups are shown in Table 1. 
Among preoperative characteristics, there was no 
case of active endocarditis, dialysis or prior cardiac 
surgery (redo) in very low-risk patients. When com-
paring risk groups, low-risk patients were older, with 
higher prevalence of women, longer cardiopulmonary 
bypass and cross-clamping times, and less isolated 
coronary surgery than in very low-risk patients.
Table 1. Preoperative population characteristics and immediate postoperative outcomes.
Variables Low-risk (n = 626) Very low-risk (n = 322) P
Pre-and intraoperative
Age [years] (range) 63.2 ± 10.0 (26–86) 58.8 ± 8.7 (35–80) < 0.0001
Male gender 502 (80.2%) 293 (91.0%) < 0.0001
Insulin dependent diabetes 7 (1.1%) 3 (0.9%) 0.945
Stroke 10 (1.6%) 5 (1.6%) 0.824
Chronic lung disease 11 (1.8%) 3 (0.9%) 0.475
Pulmonary hypertension 21 (3.4%) 5 (1.6%) 0.162
Extracardiac arteriopathy 7 (1.1%) 3 (0.9%) 0.945
Unstable angina* 17 (2.7%) 11 (4.9%) 0.547
Active endocarditis 3 (0.5%) 0 (0.0%) 0.555
Renal failure (dialysis) 2 (0.3%) 0 (0.0%) 0.551
Prior cardiac surgery (redo) 2 (0.3%) 0 (0.0%) 0.789
Moderate-severe LV dysfunction 54 (8.6%) 19 (5.9%) 0.136
Type of surgery:
Coronary 406 (64.9%) 223 (69.3%) 0.175
Valvular 171 (27.3%) 88 (27.3%) 0.997
Miscellaneous** 49 (7.8%) 11 (3.4%) 0.008
Off-pump coronary bypass*** 83 (20.4%) 44 (13.6%) 0.862
At least one IMA graft*** 393 (96.8%) 216 (96.9%) 0.191
Cardiopulmonary  
bypass time [min]
61.4 ± 11.5 59.4 ± 8.8 0.006
Cross-clamp time [min] 35.6 ± 10.6 34.1 ± 9.1 0.031
Postoperative
In-hospital mortality 11 (1.8%) 3 (0.93%) 0.404
30-day mortality 13 (2.1%) 4 (1.2%) 0.510
Operating theatre extubation 465 (74.3%) 251 (78.2%) 0.213
Major complications:
Reoperation for bleeding 12 (1.9%) 6 (1.9%) 0.954
Infarction (Q type)*** 6 (1.5%) 3 (1.3%) 0.754
Low cardiac output 4 (0.6%) 2 (0.6%) 1.000
Prolonged ventilation 3 (0.5%) 1 (0.3%) 1.000
Stroke 4 (0.6%) 0 (0.0%) 0.306
De novo dialysis 2 (0.3%) 0 (0.0%) 0.551
Mediastinitis 5 (0.8%) 3 (0.9%) 0.871
*Defined as nitrate infusion at operating theatre arrival; **Miscellaneous surgery included: cardiac neoplasm, combined surgery, ascending 
aortic aneurysm and atrial septal defect; ***Calculated exclusively for coronary surgery; LV — left ventricle; IMA — internal mammary artery
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In the low-risk group, in-hospital overall mor-
tality was 1.8% (11 observed deaths), whereas the 
one predicted by the EuroSCORE II was 1.04 ± 
± 0.41% (mean value of 7 expected deaths) (AUC 
0.765 [95% CI 0.621–0.908]). In the very low-risk 
group, in-hospital overall mortality rate was 0.93% 
(3 observed deaths), while the mortality rate 
predicted by EuroSCORE II was 0.70 ± 0.14% 
(mean value of 2 expected deaths). Thirty-day 
overall mortality in the low-risk group was 2.1% 
(13 observed deaths), and 1.2% (4 observed deaths) 
in the very-low-risk group. Regarding in-hospital 
mortality, the O/E ratio in the low-risk group was 
1.73 (95% CI 0.68–4.43); while the O/E ratio in the 
very low-risk group was 1.33 (95% CI 0.22–7.89). 
When assessing 30-day overall mortality, the 
O/E ratio in the low-risk group was 2.02 (95% CI 
0.81–5.03); while the O/E ratio in the very low- 
-risk group was 1.71 (95% CI 0.32–9.27) (Fig. 1). 
The O-E difference for in-hospital mortality in 
the low-risk group was 0.76 (95% CI –0.68–2.10); 
while in the very low-risk group it was 0.23 (95% 
CI –1.21–1.67). For 30-day mortality, the O-E dif-
ference in the low-risk group was 1.06 (95% CI 
–0.33–2.40); whereas in the very low-risk group 
it was 0.50 (95% CI –1.00–2.10) (Fig. 2).
The causes of death in low-risk patients under-
going cardiac surgery are summarized in Table 2. 
The table also identifies the problems used to 
classify death as preventable or not. Seven deaths 
out of 13 (54%) were considered preventable and 
related to renal failure due to excessive blood trans-
fusion, unresolved sternal wound complication, 
problems with anticoagulation and antiarrhythmic 
treatments, delayed pacemaker implantation, tech-
nical problem with bypass grafting and systemic 
embolism during surgery.
Discussion
Perioperative death in low-risk patients is 
uncommon and had not been thoroughly studied 
until recently [3–7]. Previous studies defined low-
-risk with a logistic EuroSCORE ≤ 2 or an additive 
EuroSCORE ≤ 3, and investigated whether death 
could be considered preventable due to a technical 
or system error. Recently, the EuroSCORE II has 
been introduced in order to adjust risk overestima-
tion attributed to the original version of the score. 
The EuroSCORE II is an update of the original 
logistic EuroSCORE model and is derived from 
a more contemporary dataset which reflects current 
cardiac surgical outcomes better [2]. Based on this 
new score we defined a low-risk population when 
expected mortality risk was ≤ 2%, and a very low-
risk population when risk was < 1%.
In this series, in-hospital mortality in patients 
with EuroSCORE II ≤ 2 was 1.8%, and 0.93% 
when the EuroSCORE II was < 1. Though surgical 
performance was adequate according to this new 
Figure 1. Observed/expected mortality ratio with the 
corresponding 95% confidence interval for in-hospital 
and 30-day overall mortality in low- and very low-risk 
groups.
Figure 2. Observed-expected mortality difference with 
the corresponding 95% confidence interval for in-hospi-
tal and 30-day overall mortality in low- and very low-risk 
groups.
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Table 2. Surgical procedure, cause of death, and problems identified in low-risk cardiac surgery  
patients, according to EuroSCORE II.
No. Gender Age Operation Time Cause of death Preventable Identified problem 
1 Female 75 CABG In-hospital Renal failure Yes — system Hemorrhage, excessive 
blood transfusion
2 Male 81 CABG+AVR In-hospital Multiple organ 
failure
No Septicemia
3 Male 61 CABG In-hospital Perioperative MI Yes — technical Problem with right  
coronary graft
4 Male 55 CABG In-hospital Perioperative MI No Hemorrhagic pericarditis 
discovered during surgery
5 Female 52 MYXOMA In-hospital Stroke Yes — technical Embolism due to  
atrial septal defect  
(right atrium myxoma)
6 Male 62 CABG In-hospital Ventricular  
arrhythmia
Yes — technical Possible inappropriate  
antiarrhythmic treatment
7 Male 72 CABG In-hospital Multiple organ 
failure
No Mediastinitis
8 Male 74 CABG In-hospital Cardiogenic shock No Unknown origin
9 Female 75 AVR In-hospital Complete  
A-V block
Yes — technical Delayed pacemaker  
implantation
10 Male 66 CABG In-hospital Cardiac vasoplegia 
syndrome
No Unknown origin
11 Male 75 CABG In-hospital Reoperation  
for bleeding
No Hemorrhage
12 Male 69 CABG 30-day Respiratory  
insufficiency
Yes — system Sternal wound  
dehiscence
13 Female 75 AVR 30-day Sudden death  
after discharge
Yes — system Potential problem  
with anticoagulation
CABG — coronary artery bypass grafting; A-V — atrioventricular; AVR — aortic valve replacement; MI — myocardial infarction
risk model standard, we found that there is still 
some room for improvement, since over half of 
deaths were potentially preventable. In previous 
studies, some unforeseen events such as stroke 
or mediastinitis were usually presumed to be non-
preventable [6]. However, a stroke could arise from 
aortic debris embolism during cross-clamping or 
from air embolism in open heart surgery, and in 
these situations, the event might be considered 
preventable. Therefore, we assumed that classifica-
tion of the causes of deaths as preventable or not 
might be affected by a high degree of subjectivity, 
and depend on identifying the actual circumstances 
and mechanisms leading to death.
The operative mortality rates for cardiac 
surgery continue to fall despite older and sicker 
patients, indicating better quality of in-hospital 
care [4]. Hence, new standards must be chosen to 
stratify surgical risk. EuroSCORE II is a challeng-
ing new standard, and nearly one-third of all our 
cardiac surgical patients were assigned as having 
a very low expected risk of mortality. Certainly, 
with this risk model, many patients with a previ-
ous logistic EuroSCORE > 2 could be reassigned 
to the low- or very low-risk groups, according to 
the EuroSCORE II.
A recent meta-analysis by Guida et al. [10], 
involving 145,592 patients, confirmed the global 
validity of EuroSCORE II as a tool to stratify pa-
tient risk. However, a single large study assessing 
the performance of this score in United Kingdom 
cardiac surgery (23,740 procedures from the Soci-
ety of Cardiothoracic Surgery Database), showed 
poor calibration for isolated coronary artery bypass 
grafting surgery in both the lowest and highest 
risk patients [11].
Since the incidence of mortality is low, the 
investigation of the cause of death in very low- 
-risk patients requires a larger group of individuals 
to demonstrate accurate mortality rates. In this 
sense, the major limitation of this work was the 
relatively small number of patients and deaths in 
the sample. Nevertheless, we determined that it is 
possible to achieve a good performance on low- and 
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very low-risk patients undergoing cardiac surgery, 
in a context of technological constraints. Although 
the observed in-hospital mortality in very low-risk 
patients was 0.93%, the expected risk based on 
the EuroSCORE II was even lower (0.70), and this 
difference could reach statistical significance in 
a larger sample.
Table 3 summarizes the findings of different 
studies analyzing death in low-risk patients and 
virtually 3 of them (from United Kingdom [3, 4] 
and Sweden [5]) showed mortality rates well be-
low 1%. The remaining 2 studies from Turkey 
reported similar results to ours, though they only 
included coronary artery bypass grafting that has 
a well-known lower risk of operative mortality than 
other types of open heart surgery [6, 7].
Conclusions
In conclusion, we propose to use and further 
validate the EuroSCORE II as a new standard for 
assessing low- and very low-risks patient out-
comes. Even in the context of the technological 
constraints occurring in a developing country, 
this risk model proved to be useful in evaluating 
the quality standards of local cardiac surgery. Ad-
ditionally, the review of cause of death in low-risk 
patients provides valuable information which may 
reveal potentially correctable issues, and eventu-
ally lead to improvements in the quality of care. 
Furthermore, the adoption of a more demanding 
standard, as the EuroSCORE II to identify low-
risk patients, avoids the sense of safety offered by 
previous versions of the score.
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study
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Freed (2009) [3] 1996–2005 4294 All type Logistic ≤ 2 0.37%
Janiec (2010) [5] 2001–2009 3924 All type Additive ≤ 3 0.38%
Farid (2013) [4] 2006–2012 2549 All type Logistic ≤ 2 0.27%
Cakalagaoglu (2014) [6] 2002–2007 2570 CABG Logistic ≤ 2 0.93%
Ercan (2014) [7] 2002–2007 478 CABG Logistic ≤ 2 1.04%
Current series 2012–2014 626 All type EuroSCORE II ≤ 2 1.76%
Current series 2012–2014 322 All type EuroSCORE II < 1 0.93%
CABG — coronary artery bypass grafting
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